Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 바이오시밀러

Anti-Human Complement Component C1s Reference Antibody (Riliprubart, RUO) (HY598026)

Anti-Human Complement Component C1s Reference Antibody (Riliprubart, RUO)
Anti-Human Complement Component C1s Reference Antibody (Riliprubart, RUO)
가격(USD):
사양:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호HY598026
설명
Riliprubart (HY598026) is a research-grade recombinant antibody targeting C1 esterase. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
종 반응성Human
응용 분야ELISA, Bioactivity: FACS, Functional assay, Research in vivo
숙주 종Human
클론성Monoclonal
이소타입IgG4-kappa
발현 시스템 Mammalian cells
타겟 C1 esterase, Complement C1s subcomponent, C1S, Complement component 1 subcomponent s
내독소 수준 < 10 EU/mg
순도 >95% purity as determined by SDS-PAGE.
정제 Protein A/G purified from cell culture supernatant.
등록번호 P09871
형태 Liquid
저장 완충액 0.01M PBS pH 7.4

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
대체 이름2756228-76-7
배경

Complement C1s subcomponent is a ~76 kDa protein. Component of the complement C1 complex, a multiprotein complex that initiates the classical pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system. C1S is activated following association of the C1 complex with immunoglobulins (IgG or IgM) complexed with antigens to form antigen-antibody complexes on the surface of pathogens. C1S is cleaved and activated by C1R to generate C1s subcomponent heavy and light chains. C1s subcomponent light chain then cleaves and activates C2 and C4, the next components of the classical complement pathway.

1. Lacroix, M. et al. (2001) The Journal of biological chemistry 276, 36233-40. PMID: 11445589
2. Kerr, FK. et al. (2005) The Journal of biological chemistry 280, 39510-4. PMID: 16169853
3. Kerr, MA. et al. (1978) The Biochemical journal 171, 99-107. PMID: 417728
4. Reboul, A. et al. (1979) FEBS letters 103, 156-61. PMID: 467643
5. McRae, BJ. et al. (1981) The Journal of biological chemistry 256, 12362-6. PMID: 6271784
6. Thielens, NM. et al. (1982) FEBS letters 141, 19-24. PMID: 6282646
7. Thielens, NM. et al. (1984) FEBS letters 165, 111-6. PMID: 6319179
8. Nagasawa, S. et al. (1977) Proceedings of the National Academy of Sciences of the United States of America 74, 2998-3001. PMID: 70787
9. Rossi, V. et al. (1998) The Journal of biological chemistry 273, 1232-9. PMID: 9422791
10. Zwarthoff, SA. et al. (2021) Proceedings of the National Academy of Sciences of the United States of America 118. PMID: 34155115
참고사항 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG4 (S228P) Recombinant Isotype Control Antibody (13R4) (HP298207)
이미지
  • Anti-Human Complement Component C1s Reference Antibody (Riliprubart, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Riliprubart.

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록